Ozempic is FDA-approved for adults with type 2 diabetes, and qualifying for a prescription typically requires a confirmed diagnosis plus documentation that diet and exercise alone aren’t controlling your blood sugar. Many people also receive it off-label for weight loss, though the eligibility criteria and insurance hurdles differ significantly depending on why you’re seeking it.
The Two FDA-Approved Uses
Ozempic has two official indications. The first is as an add-on to diet and exercise for improving blood sugar control in adults with type 2 diabetes. The second is for reducing the risk of major cardiovascular events, specifically heart attack, stroke, or cardiovascular death, in adults who have both type 2 diabetes and established heart disease.
Notably, Ozempic is not approved for weight loss on its own. A higher-dose version of the same active ingredient is approved separately for weight management under a different brand name (Wegovy), but the Ozempic label is strictly a diabetes and cardiovascular medication. That distinction matters when it comes to insurance coverage.
How Type 2 Diabetes Is Diagnosed
To qualify through the primary indication, you need a confirmed type 2 diabetes diagnosis. The American Diabetes Association uses these thresholds: an A1C of 6.5% or higher, or a fasting blood glucose of 126 mg/dL or higher. Your doctor will typically confirm with a repeat test on a separate day unless symptoms are obvious.
Ozempic is not indicated for type 1 diabetes. If your diabetes is autoimmune rather than insulin-resistance driven, this medication isn’t appropriate for you.
Off-Label Prescribing for Weight Loss
A large number of Ozempic prescriptions are written off-label for weight management in people who don’t have type 2 diabetes. In real-world data, the vast majority of people receiving Ozempic for weight loss had a BMI of 27 or higher (about 93%), and most had a BMI of 30 or higher (about 83%). The average starting BMI was roughly 36, with an average body weight around 223 pounds.
Doctors generally follow the same eligibility framework used for other weight-loss medications: a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related health condition such as high blood pressure, high cholesterol, or sleep apnea. These aren’t hard legal requirements for an off-label prescription, but they’re the standards most clinicians use, and insurance plans that do cover off-label use typically require them as well.
Who Cannot Take Ozempic
Certain conditions disqualify you entirely. Ozempic is contraindicated if you have a personal or family history of medullary thyroid carcinoma, or if you have a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It’s also contraindicated if you’ve had a serious allergic reaction to semaglutide or any of its inactive ingredients.
Beyond those absolute contraindications, clinical guidelines flag several conditions that require extreme caution or may make you ineligible:
- History of pancreatitis: The FDA label specifically notes that other diabetes treatments should be considered instead.
- Severe kidney impairment: Patients with very low kidney function (eGFR below 30) were excluded from clinical trials.
- Gallbladder disease: Semaglutide can increase the risk of gallbladder problems, so a pre-existing history warrants careful evaluation.
- Recent cardiovascular events: If you’ve had a heart attack or stroke within the past three months, you would not have been eligible for the original trials.
- Diabetic retinopathy: If you have pre-existing eye complications from diabetes, you should have a comprehensive eye exam before starting treatment, as rapid blood sugar improvements can temporarily worsen retinopathy.
Ozempic is approved only for adults. There is no pediatric approval for this specific formulation.
What Your Doctor Will Check First
Before writing a prescription, your doctor should run a set of baseline tests and review your history. Clinical guidelines recommend checking your A1C and fasting blood sugar (even if you’re not diabetic, to watch for hypoglycemia risk), kidney function, liver enzymes, pancreatic enzyme levels, and thyroid hormones including calcitonin. Elevated calcitonin levels can signal thyroid concerns that would rule out treatment.
Your doctor will also ask about your family history of thyroid cancer and any personal history of pancreatitis, gallbladder problems, or psychiatric conditions. In the major weight-loss trials, people with a history of major depressive disorder, schizophrenia, bipolar disorder, or suicide attempts were excluded. While these aren’t absolute contraindications in everyday practice, they represent areas where your doctor needs to weigh risks carefully.
Insurance Coverage and Prior Authorization
Even if you medically qualify, getting your insurance to pay for Ozempic is a separate challenge. Prior authorization requirements have increased dramatically. Among Medicare Part D plans, prior authorization for injectable semaglutide jumped from below 25% to nearly 84% by mid-2024. Private insurers have followed similar patterns.
Prior authorization typically means your doctor must submit documentation proving you meet specific criteria before the pharmacy can fill your prescription. For the diabetes indication, insurers commonly require proof of an A1C above a certain level and documentation that you’ve tried one or more less expensive diabetes medications first (a process called step therapy). For off-label weight loss use, many insurance plans simply don’t cover Ozempic at all, since it isn’t FDA-approved for that purpose.
Medicare spending on semaglutide and similar drugs surged from $57 million in 2018 to $5.7 billion in 2022, which is the driving force behind these tighter restrictions. If your prior authorization is denied, your doctor can often file an appeal with additional clinical documentation. The out-of-pocket cost without insurance typically runs over $900 per month, which is why securing coverage matters so much.
Ozempic vs. Wegovy for Weight Loss
If your primary goal is weight loss rather than blood sugar control, the medication you’re technically looking for may be Wegovy, not Ozempic. Both contain semaglutide, but Wegovy is FDA-approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition. It also reaches a higher maintenance dose.
In practice, many people end up on Ozempic for weight loss because their insurance covers it for a diabetes diagnosis but won’t cover Wegovy, or because Wegovy faces supply shortages. Your eligibility path depends heavily on whether you have a type 2 diabetes diagnosis and what your insurer is willing to authorize.